Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,130.00    80.00 (1.13%)
Bid:
7,110.00
Ask:
7,120.00
Spread: 10.00 (0.141%)
Market Cap: £9.56b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Interim Management Statement

1 Aug 2011 07:00

RNS Number : 4184L
Diploma PLC
01 August 2011
 



 

DIPLOMA PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

 

FOR IMMEDIATE RELEASE

 

1 August 2011

 

 

 

 

DIPLOMA PLC

 

SECOND INTERIM MANAGEMENT STATEMENT

IN RESPECT OF YEAR ENDING 30 SEPTEMBER 2011

 

 

Diploma PLC, the international group of businesses supplying specialised technical products and services, is today issuing its second Interim Management Statement which relates to the period from 1 April 2011 to date.

 

Group Trading Summary

The strong underlying revenue and profit performance experienced in the first half of the year has continued into the second half of the year. Revenues for the nine months to 30 June 2011 were 28% ahead of the comparable period in 2010. After adjusting for currency effects and acquisitions, underlying revenues for the nine month period increased by ca. 18%; the underlying increase in third quarter revenues was 14% against a stronger prior year comparative.

 

Operating margins have remained at similar levels to those experienced in the first half of the year, despite further incremental investment being made in headcount and operating resources to meet the significant increase in activity.

 

Sector Trading

Trading conditions remain consistent with those reported in the Interim Report in May 2011. In Life Sciences, year to date revenues are 37% ahead of the prior year comparable period. Good organic revenue growth has been boosted by currency benefits on translation and by the acquisitions of BGS and CMI in July and December 2010, respectively. In Seals, year to date revenues are 36% ahead of the prior year comparable period. Strong organic growth, in both the Aftermarket and Industrial OEM businesses, has been augmented by the acquisition of All Seals in September 2010. In Controls, year to date revenues are 14% ahead of the prior year comparable period with good organic growth, unaffected by currency or acquisitions.

 

Financial Position

The Group's cash flow generation has continued to be strong and, as anticipated at the Half Year, growth in working capital has now slowed and overall working capital should begin to fall in the final quarter of the year.

 

As at 29 July 2011, the Group had moved back into a positive net cash position (31 March 2011: £0.9m net debt) and remains well funded. There have been no other material changes in the financial position of the Group in the period since the publication of the Half Year Report for the six months ended 31 March 2011.

 

Outlook

The Directors remain confident in the outlook for the remainder of the year, given the continuing strong overall trading performance.

 

Looking further ahead, whilst recognising the global economic uncertainties and more demanding comparatives, the Group is confident of delivering "GDP-plus" levels of underlying revenue growth. To accelerate overall growth and build further value, we continue to pursue carefully selected, value-enhancing acquisitions, funded by the Group's strong balance sheet and free cash flow.

 

 

Notes:

 

1. This Interim Management Statement, which is based upon unaudited management accounts, has been prepared solely to provide additional information to the shareholders of Diploma PLC in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party for other purposes. Certain statements made in this Statement are forward-looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this Statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2. The Group's results for the year ending 30 September 2011 are expected to be released in mid November 2011.

 

3. A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

 

 

Conference Calls:

 

A telephone conference call will be held with analysts and investors at 8.00am today. Please contact Tulchan Communications for details.

 

 

Enquiries:

 

Diploma PLC -

+44 (0)20 7549 5700

Bruce Thompson, Chief Executive Officer

Nigel Lingwood, Group Finance Director

Tulchan Communications -

+44 (0)20 7353 4200

David Allchurch

Martin Robinson

 

 

NOTE TO EDITORS:

 

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

 

Diploma achieves stable growth and attractive margins from its focus on supplying specialised technical products to markets which value high levels of customer service, technical support and value adding activities. A high proportion of revenues are generated from essential products and services funded by operating, rather than capital budgets.

 

The Group employs ca. 850 employees and its principal operating businesses are located in the UK, Germany, US and Canada.

 

Over the last five years, the Group has grown adjusted earnings per share at an average of ca. 14% p.a. through a combination of organic growth and acquisitions. The current market capitalisation is ca. £420m.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEASXNAFKFEFF
Date   Source Headline
16th Jan 202010:40 amRNSResult of AGM
15th Jan 20207:00 amRNSTrading Statement
24th Dec 20197:00 amRNSDirector / PDMR Grant of LTIP Award
23rd Dec 20197:00 amRNSDirectorate Change
17th Dec 20195:09 pmRNSHolding(s) in Company
16th Dec 201912:00 pmRNSHolding(s) in Company
6th Dec 20193:27 pmRNSAnnual Financial Report & Notice of AGM
21st Nov 20194:00 pmRNSDirector/PDMR Shareholding
18th Nov 20197:00 amRNSFinal Results
8th Oct 20197:00 amRNSDirectorate Change
25th Sep 20197:00 amRNSAcquisition
10th Sep 20194:49 pmRNSHolding(s) in Company
28th Aug 20197:00 amRNSTrading Statement
8th Aug 20193:00 pmRNSHolding(s) in Company
17th Jul 20191:01 pmRNSHolding(s) in Company
11th Jul 20197:00 amRNSAcquisition
13th Jun 20192:00 pmRNSDirector Declaration
13th May 20197:00 amRNSHalf-year Report
1st Apr 20197:00 amRNSAppointment of Joint Corporate Broker
27th Mar 20197:00 amRNSHalf Year Trading Update
26th Feb 20197:00 amRNSDirector/PDMR Shareholding
25th Feb 20194:00 pmRNSDirector/PDMR Shareholding
25th Feb 20197:00 amRNSDirectorate Appointments
29th Jan 20193:30 pmRNSDirector/PDMR Shareholding
16th Jan 20194:19 pmRNSResult of AGM
16th Jan 20197:01 amRNSDirectorate Change
16th Jan 20197:00 amRNSTrading Statement
7th Dec 20184:09 pmRNSDirector/PDMR Shareholding
7th Dec 20183:00 pmRNSAnnual Financial Report & Notice of AGM
27th Nov 20184:26 pmRNSDirector/PDMR Shareholding
19th Nov 20187:00 amRNSFinal Results
12th Oct 20187:00 amRNSAcquisition
3rd Sep 20184:45 pmRNSBoard Committee Change
29th Aug 20187:01 amRNSDirectorate Change
29th Aug 20187:00 amRNSTrading Statement
22nd Aug 20187:00 amRNSAcquisition
10th Jul 20181:46 pmRNSHolding(s) in Company
12th Jun 20182:59 pmRNSHolding(s) in Company
16th May 20182:41 pmRNSDirector Declaration
15th May 20184:20 pmRNSDirector/PDMR Shareholding
15th May 20184:09 pmRNSDirector/PDMR Shareholding
14th May 20187:00 amRNSHalf-year Report
9th May 20187:00 amRNSDirectorate Change
23rd Apr 20187:00 amRNSDirectorate Change
28th Mar 20187:00 amRNSTrading Update
21st Mar 20189:30 amRNSHolding(s) in Company
20th Mar 20184:00 pmRNSHolding(s) in Company
6th Feb 20189:49 amRNSDirector/PDMR Shareholding
30th Jan 20187:00 amRNSDirectorate Change
23rd Jan 20184:00 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.